Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06243835 · ClinicalTrials.gov registry record · Phase 1
A Study to Test the Effects of Kindolor at Different Doses in Healthy Adults
A Phase 1 study, sponsored by Lohocla Research Corporation.
- Terminated
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT06243835: Clinical Trial Phase 1 study, sponsored by Lohocla Research Corporation.
NCT06243835 is a Phase 1 study that was terminated before completion, run by Lohocla Research Corporation. The registered enrollment target is 16 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06243835, a Phase 1 study, was terminated before completion, sponsored by Lohocla Research Corporation.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The goal of this study is to test Kindolor in healthy adults. The main questions it aims to answer are: * What is the safe dose of Kindolor in healthy volunteers? * How is Kindolor metabolized by the human body? Participants will undergo medical tests before and after receiving Kindolor or a placebo to see if there is any difference between the groups.
Primary Outcome
Treatment-emergent adverse events (TEAEs) were assessed starting after the first administration of investigational product until the final follow-up visit. A TEAE is defined as any AE that started or worsened in severity after the first dose of investigational product.
Interventions
- DRUG Placebo
- DRUG Kindolor Tosylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-04-21 |
| Est. Completion | 2025-02-27 |
| Phase | Phase 1 |
Why NCT06243835 stopped before completion
NCT06243835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06243835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06243835 about?
NCT06243835 is a clinical study titled "A Study to Test the Effects of Kindolor at Different Doses in Healthy Adults". The goal of this study is to test Kindolor in healthy adults. The main questions it aims to answer are: * What is the safe dose of Kindolor in healthy volunteers? * How is Kindolor metabolized by the human body? Participants will undergo medical tests before and after receiving Kindolor or a place...
What is the current status of trial NCT06243835?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2024-04-21. Estimated completion is 2025-02-27.
What interventions are being tested in trial NCT06243835?
The interventions under investigation include: Placebo (DRUG), Kindolor Tosylate (DRUG).
Who is sponsoring clinical trial NCT06243835?
This trial is sponsored by Lohocla Research Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06243835's enrollment target sits among peer trials
16 1786th of 2000 higher than 203 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI